Zhenyu Y. Ji
No. 40 Daxue Road
Zhengzhou, 450007, China
Zhengzhou, 450007, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Protein 4.1R regulates CCDC26 and impacts myeloid leukemia progression.
Journal: Cellular signalling
Published: November 29, 2025
Magnetic-vortex nanodonuts enhance ferroptosis effect of tumor ablation through an imaging-guided hyperthermia/radiosensitization strategy.
Journal: iScience
Published: March 23, 2024
Hollow magnetic vortex nanorings loaded with quercetin encapsulated in polydopamine: A high-performance, intelligent nanotheranostic platform for enhanced tumor imaging and dual thermal treatment.
Journal: International journal of pharmaceutics
Published: January 02, 2024
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 12, 2023
Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1.
Journal: Molecules (Basel, Switzerland)
Published: December 18, 2022
Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma.
Journal: Biology direct
Published: August 04, 2022
Magnetic vortex nanoring coated with gadolinium oxide for highly enhanced T1-T2 dual-modality magnetic resonance imaging-guided magnetic hyperthermia cancer ablation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 11, 2022
Advances in the study of CD47-based bispecific antibody in cancer immunotherapy.
Journal: Immunology
Published: December 15, 2021
Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies.
Journal: Frontiers in cell and developmental biology
Published: September 27, 2021
The protein 4.1R downregulates VEGFA in M2 macrophages to inhibit colon cancer metastasis.
Journal: Experimental cell research
Published: September 12, 2021
Last Updated: 09/26/2026